AstraZeneca: Just a bit of outsourcing
Did we say that? AstraZeneca is now denying any intention of outsourcing all its manufacturing, saying the EVP who'd called production "not a core activity" was misquoted. But, the company says, it will begin looking to contract manufacturers in India and China for some active ingredients in various meds.
-read this article in Pharmafocus
Related Articles:
AstraZeneca to outsource manufacturing. Report
Americans distrust drugs from China, India. Report
Research points to rapid growth of R&D outsourcing. Report
China pushes drug development as R&D soars. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
